Vitrafy Scores $30M at 32% Discount to Disrupt US Blood Cryopreservation
Vitrafy Life Sciences raised $30 million in a discounted institutional placement, aiming to disrupt the US blood storage market with its Guardion integrated platform. The raise, at a 31.6% discount, funds fleet expansion and US sales ahead of a 2027 legacy technology phase-out.